surmount study tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Clinical trials of subcutaneous tirzepatide

Starting patients on a lower dose led to fewer side effects on average

Mol Endocrinol (1996) 10(4):34255

Healthcare providers can offer recommendations and support to address side effects and ensure that treatment remains safe and effective

Semaglutide A GLP-1 receptor agonist used in FDA-approved medications for diabetes and chronic weight management under specific brand names and indications

Community culture around reta sometimes celebrates how little people can manage

For eligible and willing patients, bariatric surgery, which provides sustained benefits, may be the best option from a clinical and economic perspective